Celularity (CELUW) Change in Inventory (2020 - 2025)
Celularity (CELUW) reported Change in Inventory of -$1.7 million for Q4 2025, down 173.38% year-over-year from $2.4 million in Q4 2024, and up 25.23% quarter-over-quarter from -$2.3 million in Q3 2025.
Celularity (CELUW) Change in Inventory (2020 - 2025) Analysis & Trends
Celularity (CELUW) has 6 years of Change in Inventory data on file, last reported at -$1.7 million in Q4 2025.
- Change in Inventory for Q4 2025 came in at -$1.7 million, down 173.38% year-over-year; the trailing twelve-month figure through Dec 2025 was -$10.2 million (down 63.05% YoY), and the FY2025 annual result was -$10.2 million, down 63.05% from the prior year.
- Change in Inventory improved to -$1.7 million in Q4 2025 per CELUW's latest filing, from -$2.3 million in the prior quarter.
- Over five years, Change in Inventory peaked at $9.0 million in Q2 2022 and troughed at -$3.7 million in Q2 2025.
- A 5-year average of $382400.0 and a median of -$221000.0 in 2022 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2021 and 2023: Change in Inventory jumped 2692.16% in 2021, then tumbled 1313.11% in 2023.
- A 5-year view of Change in Inventory shows it stood at $2.6 million in 2021, then plunged by 97.69% to $61000.0 in 2022, then plunged by 1313.11% to -$740000.0 in 2023, then gained by 14.73% to -$631000.0 in 2024, then tumbled by 173.38% to -$1.7 million in 2025.
- Business Quant data shows CELUW's Change in Inventory at -$1.7 million in Q4 2025, -$2.3 million in Q3 2025, and -$3.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Celularity | - | - | -3.27 Mn | -1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.73 Mn |
| Dec 31, 2025 | -1.73 Mn |
| Sep 30, 2025 | -2.31 Mn |
| Sep 30, 2025 | -2.31 Mn |
| Jun 30, 2025 | -3.66 Mn |
| Jun 30, 2025 | -3.66 Mn |
| Mar 31, 2025 | -2.55 Mn |
| Mar 31, 2025 | -2.55 Mn |
| Dec 31, 2024 | -631,000.00 |
| Dec 31, 2024 | -631,000.00 |
| Sep 30, 2024 | -503,000.00 |
| Sep 30, 2024 | -503,000.00 |
| Jun 30, 2024 | -1.97 Mn |
| Jun 30, 2024 | -1.97 Mn |
| Mar 31, 2024 | -3.18 Mn |
| Mar 31, 2024 | -3.18 Mn |
| Dec 31, 2023 | -740,000.00 |
| Dec 31, 2023 | -740,000.00 |
| Sep 30, 2023 | -1.22 Mn |
| Sep 30, 2023 | -1.22 Mn |